|
SNX6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.280900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.070060E-02 |
| Normal-vs-Stage2 |
4.937500E-03 |
| Normal-vs-Stage3 |
1.315040E-03 |
| Normal-vs-Stage4 |
5.762500E-04 |
| Stage1-vs-Stage2 |
4.475400E-01 |
| Stage1-vs-Stage3 |
3.072200E-01 |
| Stage1-vs-Stage4 |
1.184560E-01 |
| Stage2-vs-Stage3 |
9.903600E-01 |
| Stage2-vs-Stage4 |
5.237400E-01 |
| Stage3-vs-Stage4 |
4.959400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.560600E-04 |
| Normal-vs-AfricanAmerican |
1.702200E-01 |
| Normal-vs-Asian |
2.712400E-02 |
| Caucasian-vs-AfricanAmerican |
4.224400E-01 |
| Caucasian-vs-Asian |
7.363000E-01 |
| AfricanAmerican-vs-Asian |
6.065800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.441360E-03 |
| Normal-vs-Female |
4.499400E-03 |
| Male-vs-Female |
3.897600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.214200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.840460E-04 |
| Normal-vs-Age(61-80Yrs) |
5.538400E-03 |
| Normal-vs-Age(81-100Yrs) |
9.469800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.142400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.337200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.979000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.528200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.732400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.631000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.563200E-01 |
| Classical-VS-Follicular |
2.696800E-03 |
| Classical-VS-Other |
1.416040E-01 |
| Classical-VS-Normal |
2.634500E-02 |
| Tall-VS-Follicular |
1.710650E-01 |
| Tall-VS-Other |
2.764200E-01 |
| Tall-VS-Normal |
7.911800E-02 |
| Follicular-VS-Other |
6.895400E-01 |
| Follicular-VS-Normal |
1.382860E-04 |
| Other-VS-Normal |
1.573970E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.231000E-04 |
| Normal-vs-N1 |
3.434000E-04 |
| N0-vs-N1 |
3.533000E-01 |
|
|
